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A Foregone Conclusion?
Risk Stratiﬁcation in Pacemaker-Associated Endocarditis*Thomas H. Marwick, MBBS, PHD, MPH,y Prashanthan Sanders, MBBS, PHDz
Hobart and Adelaide, AustraliaRecent European guidelines have emphasized the
association of vegetation size with embolic risk in
endocarditis (1). On these grounds, left-sided veg-
etations >1 cm, and right-sided vegetations >2 cm
are considered to be an indication for surgery. In this
issue of iJACC, investigators from the MEDIC
(Multicenter Electrophysiologic Device Cohort)
registry report the importance of vegetation size
in a group of 129 patients with pacemaker lead–
associated endocarditis (LAE) (2). LAE accountsSee page 541for approximately 20% of cardiac implantable elec-
tronic device (CIED) infections (3). Although there
is an early incidence of infection after CIED inser-
tion, it can also present months or years later. Device
infections are commonly associated with more com-
plex and prolonged procedures such as implantable
cardioverter-deﬁbrillator device implantation (with
or without cardiac resynchronization therapy). This
is known to pose the most risk to a subgroup of
older patients (more commonly men) with co-
morbid diseases (heart failure, diabetes, hyperten-
sion, and renal impairment) undergoing early pocket*Editorials published in JACC: Cardiovascular Imaging reﬂect the views
of the authors and do not necessarily represent the views of JACC:
Cardiovascular Imaging or the American College of Cardiology.
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and Sorin.re-exploration or an upgrade procedure (4). Unfor-
tunately, although the problem occurs in <0.5% to
1.5% within 1 year of implantation (4,5), the rate
of infections seems to be increasing.
Like endocarditis in general, LAE is a malignant
disease, with a 1-year mortality of 12% for pocket
infections and 25% for endovascular infections in
patients referred to the Cleveland Clinic between
2002 and 2007 (4), and a mortality of >10% in
this study by Greenspon et al. (2). About one-half
of the incremental long-term mortality occurs after
discharge (5). Current treatment is based upon the
use of parenteral antibiotics and lead removal (6),
which may be surgical if vegetations are large. CIED
infection not only causes increased acute and long-
term mortality, but also carries a substantial cost
burden, related mainly to intensive care (5). In that
cost analysis, the standardized adjusted incremental
cost that is due to infection was $14,360 to $16,498.
A better method for evaluating risk might allow
prioritization of interventions.
The results of this study by Greenspon et al. (2)
show that patients with small (<1 cm) vegetations
were more likely to present with features of pocket
infection. The same database has previously been
used to document that LEA with small vegetations
usually occurs early after implantation (6) (probably
from spread of pocket infection to the leads) and that
55% of patients with CIED pocket infection present
<12 months following their last CIED-related
procedure (7). Patients with early infection present
with localized inﬂammation and are more likely to
be female and on anticoagulation. By contrast, larger
(>1 cm) vegetationsdknown to present later after
implantationdwere more likely associated with evi-
dence of systemic infection, likely related to hema-
togenous spread from other foci. Patients with larger
vegetations were older and more likely to have co-
morbid disease, including coronary disease. Previous
J A C C : C A R D I O V A S C U L A R I M A G I N G , V O L . 7 , N O . 6 , 2 0 1 4 Marwick and Sanders
J U N E 2 0 1 4 : 5 5 0 – 2 Editorial Comment
551work has shown both Staphylococcus aureus and
coagulase-negative staphylococci to be involved in
CIED, with no differences in microbiology to sup-
port a 1-year cutoff between early and late CIED
infection (8). About 20% of all CIED-related in-
fections are due to non-staphylococcal organisms,
although outcomes seem similar in all groups (9).
The publication emphasizes the value of registries
in gathering insight regarding the presentations
and outcomes of uncommon illnesses by gathering
data at multiple high-volume centers (2). None-
theless, some design aspects are imperfect. A sys-
tematic process for reviewing images would have
reassured the reader that the same approach was
used for image acquisition as well as measurement.
The selection of a 1-cm cutoff as a meaningful
number regarding vegetation size is arbitrary.
Length measurement may be difﬁcult in a highly
mobile lesion that may be partially out of the ul-
trasound plane. Recent work has emphasized that
vegetation length from 2-dimensional (2D) trans-
esophageal echocardiography was 3.2 mm (95%
conﬁdence interval: 2.1 to 4.2 mm) less than the
length estimated from 3D imaging, which was more
accurate than 2D imaging for the prediction of
embolic events (10). Even 3D imaging may not
permit accurate measurement if the lesion is moving
across planes, and the spatial resolution of this
technique may introduce other challenges to the
detection of thin, friable structures.
In the context of these ﬁndings, vegetation
length should not be considered to be central in
clinical management of LAE. First, lead masses do
not necessarily constitute vegetations, and as
mentioned earlier in the text, the measurement of
vegetation length can be difﬁcult. Second, LAE is
a malignant illness, with a mortality of >10%, with
no difference in the outcomes of the groups based
upon vegetation size (2). Third, the differences
between groups may simply reﬂect time bias leading
to confounding by the duration of illness. Finally,
complete removal of hardware is necessary and
widely performed in LAE (11), and the appropri-
ateness of this strategy was conﬁrmed by the ﬁndingin this study (2) that patient outcomes seemed to be
better with device removal than in those treated
medically. Indeed, in a recent study of 151 patients
with device infections who underwent successful
treatment including extraction and reimplantation
showed no difference in all-cause mortality, with
patients with biventricular devices never known
to become infected (p ¼ 0.21). The ﬁnding of
similar outcomes with small and large vegetations
in the current paper (2) supports the performance
of lead extraction once there is evidence of sys-
temic infection or evidence of lead or valvular
endocarditis (12).
The best strategy for CIED infection is preven-
tion, including meticulous aseptic technique and
prophylactic antibiotics, minimizing exposure and
handling of the device, and potentially including an
antibacterial envelope (13). If this fails, the results
of this study support early diagnosis and aggressive
intervention. LAE is associated with short- and
long-term mortality, independent of age, renal fail-
ure, heart failure, cancer, and immune suppression
(14). Suspected LAE should provoke performance
of transesophageal echocardiographydpreferably
3D because it has higher sensitivity for infection (9).
Vegetations are easily missed in the superior vena
cava, which requires careful evaluation in the
bicaval view. As recently published in iJACC, la-
beled autologous white blood cell scintigraphy has
a high sensitivity (94%) for device infection, espe-
cially LAE (15), exceeding those of echocardiog-
raphy (81%) and Duke criteria (31%). Likewise,
18F-ﬂuorodeoxyglucose positron emission tomog-
raphy has a potential role when the diagnosis is
suspected but not conﬁrmed (16).
The use of these imaging in LAE is to ensure
early diagnoses. Once the diagnosis is made, the
management policy should be clear, irrespective of
the imaging ﬁndings.
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